Typically, tumors are
assessed through invasive
tumor biopsies or through
radioactive scans. This
latest technique allows
earlier assessment with
minimal discomfort to
patients. “Liquid biopsy
is a paradigm shift that
involves a minimally-
invasive procedure, no
radioactive scans, and can
CDSCO approves first
autologous dendritic
cell-based immuno-
oncology product
Indian biotechnology
company, APAC Biotech,
was granted with a
commercial license by
Central Drugs Standard
Control Organization
(CDSCO), the Indian FDA,
to market its product,
APCEDEN, a dendritic
cell-based autologous
immuno-oncology
product for four cancer
indications namely
Prostate, Ovarian, Colo-
rectal and Non-Small
Cell Lung carcinoma.
The company says that
the Indian Food and
Drug Administration
authorities, after
their stringent review
of the application,
have issued the
commercial license
(Form 46) to conduct
a post marketing
surveillance on
statistically significant
number of patients
for each indication.
of cancer reported in
2020 and over 8.8 lakhs
patients are expected
to die from the disease.
In this backdrop, the
Strand Life Sciences has
announced the launch
of their Liquid Biopsy
test portfolio ‘STRAND
LB’ that provides highly
sensitive detection of
tumor traces from a
simple blood draw.
This powerful tool
can provide early and
precise indication of
tumor presence, cancer
recurrence, and response
to therapy compared to
any other method used
in the medical industry.
detect tumor DNA traces
from a simple blood draw.
However, detecting tumor
DNA requires a highly
sensitive test capable
of detecting 1 molecule
in 1000. Our study on
patients spanning a wide
variety of cancer types –
including lung, colorectal,
breast, and bladder cancer
- shows that STRAND LB
can detect tumor DNA
traces in as many as 35%
of patients with early-
stage cancer, going up
to 70-90% in patients
with locally advanced or
metastatic cancer. These
figures are at par with the
best in the world”, said Dr
Vijay Chandru, Chairman
and Managing Director,
Strand Life Sciences.
Other products namely
STEMPEUCEL,
allogeneic-cultured
mesenchymal cells
from Stempeutics
and OSSORON, an
autologous-cultured
adult osteoblast and
CHONDRON, an
autologous-cultured
adult chondrocyte from
Regenerative Medical
Services, Mumbai, also
BIOVOICENEWS.COM
65